FDA NDC Directory · JSON-LD · Markdown

Dabigatran Etexilate

NDC 67877-624 · HUMAN PRESCRIPTION DRUG · CAPSULE, COATED PELLETS

Labeler / ManufacturerAscend Laboratories, LLC
Marketing categoryAbbreviated NDA (generic) · App ANDA208040
Dosage form / routeCAPSULE, COATED PELLETS · ORAL
Active ingredientsDABIGATRAN ETEXILATE MESYLATE (110 mg/1)
Marketing started20250912
Package count2

External sources

Source: openFDA. Public-domain (CC0).